Explore the words cloud of the ADMAIORA project. It provides you a very rough idea of what is the project "ADMAIORA" about.
The following table provides information about the project.
SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA
|Coordinator Country||Italy [IT]|
|Total cost||5˙397˙480 €|
|EC max contribution||5˙397˙480 € (100%)|
1. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
|Duration (year-month-day)||from 2019-01-01 to 2023-01-31|
Take a look of project's partnership.
|1||SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA||IT (PISA)||coordinator||1˙071˙500.00|
|2||ISTITUTO ORTOPEDICO RIZZOLI||IT (BOLOGNA)||participant||1˙112˙500.00|
|3||IMAGE GUIDED THERAPY SA||FR (PESSAC)||participant||670˙500.00|
|4||REGENTIS BIOMATERIALS LTD||IL (OR AKIVA)||participant||609˙250.00|
|5||HITECH DEVELOPMENT WIRELESS SWEDENAB||SE (KISTA)||participant||576˙930.00|
|6||BAR ILAN UNIVERSITY||IL (RAMAT GAN)||participant||524˙800.00|
|7||VIMEX SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA||PL (GLIWICE)||participant||506˙375.00|
|8||PLASMACHEM PRODUKTIONS- UND HANDEL GMBH||DE (BERLIN)||participant||325˙625.00|
Osteoarthritis (OA) is a major burden that affects ~ 40 million of EU citizens, with enormous direct and indirect costs for the European healthcare systems, quantified in ~ 50.4 billion euros per year. This disease involves the degeneration of cartilage and other joint structures and is one of the most common causes of pain and disability in middle-aged and elderly people. ADMAIORA aims in the long-term at increasing the healthy and active lifespan of people affected by OA, by considerably slowing down or even stopping the degeneration process, thus delaying or avoiding surgical interventions for total joint replacement. Within the project time-frame the target is to achieve a 60% reduction of degeneration in OA animal models treated with the ADMAIORA technologies, with respect to control (untreated) ones, after 4 weeks, and a 90% reduction after 3 months. To achieve this ambitious objective the Consortium will evolve and merge technologies that already showed a high potential as experimental proof of concepts (TRL = 3) and will bring them at a preclinical level (TRL = 5). The ADMAIORA Consortium will develop biosynthetic hydrogels embedded with carbon-based nanomaterials, conferring higher mechanical and lubrication properties, and piezoelectric nanoparticles enabling responsivity to remote wireless ultrasound waves. Stem cells derived from autologous adipose tissue, which already demonstrated anti-inflammatory and regenerative properties, will be entrapped in the hydrogels. Materials and cells will be delivered in situ through an innovative handheld 3D bioprinter, embedded in an arthroscopic tool. A custom brace will be designed and equipped with ultrasound probes for both monitoring the joint status and stimulating the implanted piezoelectric nanobiomaterial. A dedicated App will allow a direct connection between patient and physician in an Internet of Things framework. Overall, ADMAIORA will target a ground-breaking paradigm that may revolutionize OA treatment.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ADMAIORA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ADMAIORA" are provided by the European Opendata Portal: CORDIS opendata.
MEFISTO - Meniscal functionalised scaffold to prevent knee Osteoarthritis onset after meniscectomyRead More
Recycling and Repurposing of Plastic Waste for Advanced 3D Printing ApplicationsRead More
A testing bed for the development of high-risk medical devicesRead More